Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5901
    -0.0005 (-0.08%)
     
  • NZD/EUR

    0.5526
    -0.0018 (-0.33%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    83.18
    +0.45 (+0.54%)
     
  • GOLD

    2,403.20
    +5.20 (+0.22%)
     
  • NASDAQ

    17,208.32
    -185.99 (-1.07%)
     
  • FTSE

    7,872.06
    -4.99 (-0.06%)
     
  • Dow Jones

    37,907.99
    +132.61 (+0.35%)
     
  • DAX

    17,745.02
    -92.38 (-0.52%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    91.1360
    -0.1180 (-0.13%)
     

Up 40% in 1 Day, Is Novavax Stock a Buy Now?

Up 40% in 1 Day, Is Novavax Stock a Buy Now?

On May 9, Novavax (NASDAQ: NVAX) shareholders got a much-needed reprieve from the stock's downward trajectory over the last year. Novavax's decline is a regrettable one. Its coronavirus vaccine candidate ran into regulatory issues during clinical development, and arrived on the market much later than those of competitors like Pfizer and Moderna.